TRH and neoplasm: Immunohistochemical studies revealed diffuse co-secretion of both TRH and TSH by the tumor, with diffuse expression of lineage-restricted transcription factors (ie, Pit-1 and GATA-2), which may have resulted in a continuous autocrine/paracrine regulation of TSH secretion.